A Study of Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib
Clinical trial NCT00706953 · WITHDRAWN
Trial details
- NCT number
- NCT00706953
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2010-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.